THEMIS MEDICARE LTD. - 530199 - Board Meeting Outcome for Outcome Of The Board Meeting
The Board of Directors at its meeting held today, considered and approved the Unaudited Standalone and Consolidated Financial Results for the Quarter ended 30th June, 2022. A copy of Unaudited Standalone and Consolidated Financial Results for the Quarter ended 30th June, 2022 is enclosed herewith. This may be taken as compliance under the Listing Regulations. THEMIS MEDICARE LTD. - 530199 - Board Meeting Intimation for Approval Of Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30, 2022
THEMIS MEDICARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/07/2022 ,inter alia, to consider and approve With respect to the captioned subject, please be informed that a meeting of the Board of Directors of Themis Medicare Limited is scheduled to be held on Thursday,28th July, 2022 inter alia, to consider, the Un-audited Standalone and Consolidated Financial Results for the quarter ended on 30th June, 2022. We request you to take the same on record. THEMIS MEDICARE LTD. - 530199 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
We are enclosing herewith a Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2022 received from Link lntime India Pvt. Ltd., Registrar and Share Transfer Agent of our Company. This is for your information and record. THEMIS MEDICARE LTD. - 530199 - Announcement under Regulation 30 (LODR)-Credit Rating
We would like to inform you that based on rating assessment undertaken by CARE Ratings Limited, the rating assigned to the Company by the CARE Ratings Limited as under: Facilities Amount (Rs. Crore) Rating Long Term Bank Facilities 65.38 (Enhanced from 21.15) CARE BB+; Stable (Double B Plus; Outlook: Stable) Short Term Bank Facilities 63.25 CARE A4+ (A Four Plus) Total Facilities 128.63 (Rs. One Hundred Twenty-Eight Crore and Sixty-Three Lakhs Only) We request you to take the same on record. THEMIS MEDICARE LTD. - 530199 - Closure of Trading Window
We would like to inform you that as per the Company''s minimum Standards Code of Conduct to regulate, monitor and report trading by its Employees and other Connected Persons under SEBI (Prohibition of Insider Trading) Regulations, 2015 (as amended) (PIT Regulations) and pursuant to BSE Circular Ref No: LIST/COMP /01/2019-20 dated 2nd April, 2019 and NSE Circular Ref No. NSE/CML/2019/11 on the provisions of Clause 4 of the Schedule B of the PIT regulations, the Trading Window for dealing in the Securities of the Company shall remain closed on and from Friday 1st July, 2022 and will re-open after completion of 48 hours from the declaration of financial results for the quarter ended 30th June, 2022 by the Board of Directors of the Company. THEMIS MEDICARE LTD. - 530199 - Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Themis Medicare Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here THEMIS MEDICARE LTD. - 530199 - Declaration Of Voting Results Of Postal Ballot (E-Voting)
Pursuant to Regulation 44(3) of the SEBI (LODR) Regulations, 2015, we are enclosing herewith the Report submitted by the Scrutinizer i.e. Mr. Shirish Shetye (FCS 1926), Designated Partners of M/s. SAV & Associates LLP, Practicing Company Secretaries, Mumbai along with the voting results declared on (Friday) June 17, 2022, with respect to the Postal Ballot (e-voting) conducted by the Company for seeking approval of the Members by way of Special/Ordinary Resolution for the following Special Business contained in the Postal Ballot Notice dated May 10, 2022: 1. RE-APPOINTMENT OF DR. DINESH S. PATEL AS THE WHOLE TIME DIRECTOR OF THE COMPANY. 2. RE-APPOINTMENT OF DR. SACHIN D. PATEL AS THE MANAGING DIRECTOR & CHIEF EXECUTIVE OFFICER OF THE COMPANY. A duly certified copy of the Report of the Scrutinizer in this regard is also enclosed herewith. Kindly acknowledge the receipt and take the same on your record. THEMIS MEDICARE LTD. - 530199 - Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements), 2015
Pursuant to Regulation 23(9) of Listing Regulations, please find enclosed disclosure of Related Party Transactions on a consolidated basis for the half year ended 31st March 2022. Kindly take the same on your records. THEMIS MEDICARE LTD. - 530199 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Pursuant to Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended) read with SEBI Circular CIR/CFD/ CMD1/27/2019 dated February 8, 2019, please find enclosed the Annual Secretarial Compliance Report of the Company issued by SAV & Associates LLP, Company Secretaries for the financial year 2021 -22. This is for the information of the exchange and the members. THEMIS MEDICARE LTD. - 530199 - Announcement under Regulation 30 (LODR)-Newspaper Publication
In terms of Regulations 47 of SEBI(LODR) Regulations, 2015 the company has published the audited Financial Results for the quarter and year ended March 31,2022 in ''Western Times'' (English) edition dated Monday, May 23,2022 & in Western Times'' (Gujarati) edition dated Monday, May 23,2022. Further, in pursuance of Regulation 30 read with Schedule III (A) (12) please find enclosed the copy of Newspaper articles as published in the above mentioned newspapers. Kindly take the same on record and acknowledge receipt.